Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score.

Szijgyarto Z, Rampat R, Werner GS, Ho C, Reifart N, Lefevre T, Louvard Y, Avran A, Kambis M, Buettner HJ, Di Mario C, Gershlick A, Escaned J, Sianos G, Galassi A, Garbo R, Goktekin O, Meyer-Gessner M, Lauer B, Elhadad S, Bufe A, Boudou N, Sievert H, Martin-Yuste V, Thuesen L, Erglis A, Christiansen E, Spratt J, Bryniarski L, Clayton T, Hildick-Smith D.

JACC Cardiovasc Interv. 2019 Feb 25;12(4):335-342. doi: 10.1016/j.jcin.2018.11.020. Epub 2019 Jan 30.

PMID:
30711551
2.

SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate.

Matyskiela ME, Couto S, Zheng X, Lu G, Hui J, Stamp K, Drew C, Ren Y, Wang M, Carpenter A, Lee CW, Clayton T, Fang W, Lu CC, Riley M, Abdubek P, Blease K, Hartke J, Kumar G, Vessey R, Rolfe M, Hamann LG, Chamberlain PP.

Nat Chem Biol. 2018 Oct;14(10):981-987. doi: 10.1038/s41589-018-0129-x. Epub 2018 Sep 6.

PMID:
30190590
3.

Rationale and design of: A Randomized tRial of Expedited transfer to a cardiac arrest center for non-ST elevation out-of-hospital cardiac arrest: The ARREST randomized controlled trial.

Patterson T, Perkins A, Perkins GD, Clayton T, Evans R, Nguyen H, Wilson K, Whitbread M, Hughes J, Fothergill RT, Nevett J, Mosweu I, McCrone P, Dalby M, Rakhit R, MacCarthy P, Perera D, Nolan JP, Redwood SR.

Am Heart J. 2018 Oct;204:92-101. doi: 10.1016/j.ahj.2018.06.016. Epub 2018 Aug 6.

PMID:
30092413
4.

Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.

Perera D, Clayton T, Petrie MC, Greenwood JP, O'Kane PD, Evans R, Sculpher M, Mcdonagh T, Gershlick A, de Belder M, Redwood S, Carr-White G, Marber M; REVIVED investigators.

JACC Heart Fail. 2018 Jun;6(6):517-526. doi: 10.1016/j.jchf.2018.01.024.

5.

Ethical Issues with Genetic Testing for Tay-Sachs.

Clayton T.

J Christ Nurs. 2017 Oct/Dec;34(4):246-249. doi: 10.1097/CNJ.0000000000000426.

PMID:
28902054
6.

Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality.

Bulluck H, Maiti R, Chakraborty B, Candilio L, Clayton T, Evans R, Jenkins DP, Kolvekar S, Kunst G, Laing C, Nicholas J, Pepper J, Yellon DM, Hausenloy DJ.

Heart. 2017 Aug 9. pii: heartjnl-2017-311760. doi: 10.1136/heartjnl-2017-311760. [Epub ahead of print]

7.

Distinguishing between those dying suddenly or not suddenly from coronary heart disease: long-term prospective results from the Northwick Park Heart Study.

Meade T, Clayton T, Chamberlain D.

Open Heart. 2016 Dec 5;3(2):e000440. doi: 10.1136/openhrt-2016-000440. eCollection 2016.

8.

Impact of call-to-balloon time on 30-day mortality in contemporary practice.

Varcoe RW, Clayton TC, Gray HH, de Belder MA, Ludman PF, Henderson RA; British Cardiovascular Intervention Society (BCIS) and the National Institute for Cardiovascular Outcomes Research (NICOR).

Heart. 2017 Jan 15;103(2):117-124. doi: 10.1136/heartjnl-2016-309658. Epub 2016 Jul 13.

9.

Effect of Remote Ischaemic preconditioning on Clinical outcomes in patients undergoing Coronary Artery bypass graft surgery (ERICCA study): a multicentre double-blind randomised controlled clinical trial.

Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas JM, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM.

Southampton (UK): NIHR Journals Library; 2016 Jun.

10.

Description of artefacts in the PowerPlex Y23(®) system associated with excessive quantities of background female DNA.

Moore D, Clayton T, Thomson J.

Forensic Sci Int Genet. 2016 Sep;24:44-50. doi: 10.1016/j.fsigen.2016.05.009. Epub 2016 May 19.

PMID:
27288717
11.

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study.

Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, Minassian C, Langan SM.

Neurology. 2016 Jul 5;87(1):94-102. doi: 10.1212/WNL.0000000000002808. Epub 2016 Jun 10.

12.

Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?

Henderson RA, Jarvis C, Clayton T, Pocock SJ, Fox KAA.

J Am Coll Cardiol. 2016 Mar 29;67(12):1502-1503. doi: 10.1016/j.jacc.2015.12.064. No abstract available.

13.

A 10-year prognostic model for patients with suspected angina attending a chest pain clinic.

Sekhri N, Perel P, Clayton T, Feder GS, Hemingway H, Timmis A.

Heart. 2016 Jun 1;102(11):869-75. doi: 10.1136/heartjnl-2015-308994. Epub 2016 Feb 29.

14.

Reply: Survival Differences in Clinical Trials With Long-Term Follow-up.

Henderson RA, Jarvis C, Clayton T, Pocock SJ, Fox KA.

J Am Coll Cardiol. 2016 Feb 9;67(5):601. doi: 10.1016/j.jacc.2015.10.087. No abstract available.

15.

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.

Ling TC, Clayton TH, Crawley J, Exton LS, Goulden V, Ibbotson S, McKenna K, Mohd Mustapa MF, Rhodes LE, Sarkany R, Dawe RS.

Br J Dermatol. 2016 Jan;174(1):24-55. doi: 10.1111/bjd.14317. No abstract available.

PMID:
26790656
16.

Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials.

Pocock SJ, Clayton TC, Stone GW.

J Am Coll Cardiol. 2015 Dec 29;66(25):2886-2898. doi: 10.1016/j.jacc.2015.10.051. Review.

17.

Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical Trials.

Pocock SJ, Clayton TC, Stone GW.

J Am Coll Cardiol. 2015 Dec 22;66(24):2757-2766. doi: 10.1016/j.jacc.2015.10.036. Review.

18.

A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.

Clayton T, Poe MM, Rallapalli S, Biawat P, Savić MM, Rowlett JK, Gallos G, Emala CW, Kaczorowski CC, Stafford DC, Arnold LA, Cook JM.

Int J Med Chem. 2015;2015:430248. doi: 10.1155/2015/430248. Epub 2015 Nov 10. Review.

19.

Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.

Yu J, Mehran R, Clayton T, Gibson CM, Brodie BR, Witzenbichler B, Lincoff AM, Deliargyris EN, Gersh BJ, Pocock SJ, Stone GW, Dangas GD.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):391-400. doi: 10.1002/ccd.26146. Epub 2015 Dec 1.

PMID:
26624854
20.

Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.

Wedgeworth E, Glover M, Irvine AD, Neri I, Baselga E, Clayton TH, Beattie PE, Bjerre JV, Burrows NP, Foelster-Holst R, Hedelund L, Hernandez-Martin A, Audrain H, Bhate K, Brown SJ, Baryschpolec S, Darne S, Durack A, Dvorakova V, Gach J, Goldstraw N, Goodyear H, Grabczynska S, Greenblatt D, Halpern J, Hearn RM, Hoey S, Hughes B, Jayaraj R, Johansson EK, Lam M, Leech S, O'Regan GM, Morrison D, Porter W, Ramesh R, Schill T, Shaw L, Taylor AE, Taylor R, Thomson J, Tiffin P, Tsakok M, Janmohamed SR, Laguda B, McPherson T, Oranje AP, Patrizi A, Ravenscroft JC, Shahidullah H, Solman L, Svensson A, Wahlgren CF, Hoeger PH, Flohr C.

Br J Dermatol. 2016 Mar;174(3):594-601. doi: 10.1111/bjd.14233. Epub 2015 Dec 26.

PMID:
26473312
21.

Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Hausenloy DJ, Kharbanda R, Rahbek Schmidt M, Møller UK, Ravkilde J, Okkels Jensen L, Engstrøm T, Garcia Ruiz JM, Radovanovic N, Christensen EF, Sørensen HT, Ramlall M, Bulluck H, Evans R, Nicholas J, Knight R, Clayton T, Yellon DM, Bøtker HE.

Eur Heart J. 2015 Aug 1;36(29):1846-8.

PMID:
26460398
22.

Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.

Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM; ERICCA Trial Investigators.

N Engl J Med. 2015 Oct 8;373(15):1408-17. doi: 10.1056/NEJMoa1413534. Epub 2015 Oct 5.

23.
24.

A systematic review and meta-analysis of risk factors for postherpetic neuralgia.

Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, Langan SM.

Pain. 2016 Jan;157(1):30-54. doi: 10.1097/j.pain.0000000000000307. Review.

25.
26.

Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.

Hayashi Y, Caboni L, Das D, Yumoto F, Clayton T, Deller MC, Nguyen P, Farr CL, Chiu HJ, Miller MD, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Tomoda K, Conklin BR, Wilson IA, Yamanaka S, Fletterick RJ.

Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4666-71. doi: 10.1073/pnas.1502855112. Epub 2015 Mar 30.

27.

A novel mutation in IL36RN underpins childhood pustular dermatosis.

Ellingford JM, Black GC, Clayton TH, Judge M, Griffiths CE, Warren RB.

J Eur Acad Dermatol Venereol. 2016 Feb;30(2):302-5. doi: 10.1111/jdv.13034. Epub 2015 Feb 16.

28.

Reply: Long-term follow-up of elective chronic total coronary occlusion angioplasty.

George S, Cockburn J, Clayton TC, Ludman P, Cotton J, Spratt J, Redwood S, de Belder M, de Belder A, Hill J, Hoye A, Palmer N, Rathore S, Gershlick A, Di Mario C, Hildick-Smith D.

J Am Coll Cardiol. 2014 Dec 23;64(24):2709-2710. doi: 10.1016/j.jacc.2014.10.004. No abstract available.

29.

Individualizing treatment choices using quantitative methods.

Pocock SJ, Stone GW, Mehran R, Clayton TC.

Am Heart J. 2014 Nov;168(5):607-10. doi: 10.1016/j.ahj.2014.08.003. Epub 2014 Aug 10. No abstract available.

PMID:
25440787
30.

Peak flow rate and death due to coronary heart disease: 30-year results from the Northwick Park Heart cohort study.

Clayton TC, Meade TW, Turner EL, De Stavola BL.

Open Heart. 2014 Oct 8;1(1):e000164. doi: 10.1136/openhrt-2014-000164. eCollection 2014.

31.

Impact of an invasive strategy on 5 years outcome in men and women with non-ST-segment elevation acute coronary syndromes.

Alfredsson J, Clayton T, Damman P, Fox KA, Fredriksson M, Lagerqvist B, Wallentin L, de Winter RJ, Swahn E.

Am Heart J. 2014 Oct;168(4):522-9. doi: 10.1016/j.ahj.2014.06.025. Epub 2014 Jul 13. Review.

PMID:
25262262
32.

Quantification of risk factors for herpes zoster: population based case-control study.

Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM.

BMJ. 2014 May 13;348:g2911. doi: 10.1136/bmj.g2911.

33.

Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database.

George S, Cockburn J, Clayton TC, Ludman P, Cotton J, Spratt J, Redwood S, de Belder M, de Belder A, Hill J, Hoye A, Palmer N, Rathore S, Gershlick A, Di Mario C, Hildick-Smith D; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research.

J Am Coll Cardiol. 2014 Jul 22;64(3):235-43. doi: 10.1016/j.jacc.2014.04.040. Erratum in: J Am Coll Cardiol. 2014 Oct 7;64(14):1538.

34.

Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational study.

Perel P, Clayton T, Altman DG, Croft P, Douglas I, Hemingway H, Hingorani A, Morley KI, Riley R, Timmis A, Van der Windt D, Roberts I; PROGRESS Partnership.

PLoS Med. 2014 Jun 17;11(6):e1001664. doi: 10.1371/journal.pmed.1001664. eCollection 2014 Jun.

35.

Evidential evaluation of DNA profiles using a discrete statistical model implemented in the DNA LiRa software.

Puch-Solis R, Clayton T.

Forensic Sci Int Genet. 2014 Jul;11:220-8. doi: 10.1016/j.fsigen.2014.04.005. Epub 2014 Apr 19.

PMID:
24815372
36.

Birthweight and the risk of atopic diseases: the ISAAC Phase III study.

Mitchell EA, Clayton T, García-Marcos L, Pearce N, Foliaki S, Wong G; ISAAC Phase Three Study Group.

Pediatr Allergy Immunol. 2014 May;25(3):264-70. doi: 10.1111/pai.12233_1.

PMID:
24750571
37.

The bimolecular structure of aquahexa-μ-chlorido-μ4-oxido-tris(tetrahydrofuran-κO)tetracopper(II)-hexa-μ-chlorido-μ4-oxido-tetrakis(tetrahydrofuran-κO)tetracopper(II)-tetrahydrofuran (2/1/4).

Wheeler KA, Helgren TR, Clayton TW Jr.

Acta Crystallogr C Struct Chem. 2014 Mar;70(Pt 3):306-11. doi: 10.1107/S205322961400374X. Epub 2014 Feb 28.

PMID:
24594723
38.

Bivalirudin started during emergency transport for primary PCI.

Steg PG, van 't Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo dell' Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P; EUROMAX Investigators.

N Engl J Med. 2013 Dec 5;369(23):2207-17. doi: 10.1056/NEJMoa1311096. Epub 2013 Oct 30.

39.

Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).

Stone GW, Clayton T, Deliargyris EN, Prats J, Mehran R, Pocock SJ.

J Am Coll Cardiol. 2014 Jan 7-14;63(1):15-20. doi: 10.1016/j.jacc.2013.09.027. Epub 2013 Oct 16.

40.

Poison ivy dermatitis.

Colbeck C, Clayton TH, Goenka A.

Arch Dis Child. 2013 Dec;98(12):1022. doi: 10.1136/archdischild-2013-305122. Epub 2013 Sep 12. No abstract available.

PMID:
24030248
41.

Time trends, ethnicity and risk factors for eczema in New Zealand children: ISAAC Phase Three.

Clayton T, Asher MI, Crane J, Ellwood P, Mackay R, Mitchell EA, Moyes CD, Pattemore P, Pearce N, Stewart AW.

Asia Pac Allergy. 2013 Jul;3(3):161-78. doi: 10.5415/apallergy.2013.3.3.161. Epub 2013 Jul 30.

42.

Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected].

Soto PL, Ator NA, Rallapalli SK, Biawat P, Clayton T, Cook JM, Weed MR.

Neuropsychopharmacology. 2013 Oct;38(11):2315-25. doi: 10.1038/npp.2013.137. Epub 2013 May 31. Erratum in: Neuropsychopharmacology. 2013 Nov;38(12):2553.

43.

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.

Kong L, Lee JH, Doores KJ, Murin CD, Julien JP, McBride R, Liu Y, Marozsan A, Cupo A, Klasse PJ, Hoffenberg S, Caulfield M, King CR, Hua Y, Le KM, Khayat R, Deller MC, Clayton T, Tien H, Feizi T, Sanders RW, Paulson JC, Moore JP, Stanfield RL, Burton DR, Ward AB, Wilson IA.

Nat Struct Mol Biol. 2013 Jul;20(7):796-803. doi: 10.1038/nsmb.2594. Epub 2013 May 26.

44.

Information coding in vasopressin neurons--the role of asynchronous bistable burst firing.

MacGregor DJ, Clayton TF, Leng G.

Biosystems. 2013 May;112(2):85-93. doi: 10.1016/j.biosystems.2013.03.010. Epub 2013 Mar 14.

45.

Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention.

Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S; BCIS-1 Investigators.

Circulation. 2013 Jan 15;127(2):207-12. doi: 10.1161/CIRCULATIONAHA.112.132209. Epub 2012 Dec 6.

PMID:
23224207
46.

The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials.

Flather M, Rhee JW, Boothroyd DB, Boersma E, Brooks MM, Carrié D, Clayton TC, Danchin N, Hamm CW, Hueb WA, King SB, Pocock SJ, Rodriguez AE, Serruys P, Sigwart U, Stables RH, Hlatky MA.

J Am Coll Cardiol. 2012 Nov 20;60(21):2150-7. doi: 10.1016/j.jacc.2012.08.982.

47.

Modulation of α5 subunit-containing GABAA receptors alters alcohol drinking by rhesus monkeys.

Rüedi-Bettschen D, Rowlett JK, Rallapalli S, Clayton T, Cook JM, Platt DM.

Alcohol Clin Exp Res. 2013 Apr;37(4):624-34. doi: 10.1111/acer.12018. Epub 2012 Nov 5.

48.

Time trends and risk factors for rhinoconjunctivitis in New Zealand children: an International Study of Asthma and Allergies in Childhood (ISAAC) survey.

Moyes CD, Clayton T, Pearce N, Asher MI, Ellwood P, Mackay R, Mitchell E, Pattemore P, Stewart AW, Crane J.

J Paediatr Child Health. 2012 Oct;48(10):913-20. doi: 10.1111/j.1440-1754.2012.02518.x. Epub 2012 Aug 17.

PMID:
22897723
49.

Predicting early death in patients with traumatic bleeding: development and validation of prognostic model.

Perel P, Prieto-Merino D, Shakur H, Clayton T, Lecky F, Bouamra O, Russell R, Faulkner M, Steyerberg EW, Roberts I.

BMJ. 2012 Aug 15;345:e5166. doi: 10.1136/bmj.e5166.

50.

Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE).

Cockburn J, Behan M, de Belder A, Clayton T, Stables R, Oldroyd K, Curzen N, Hildick-Smith D.

Heart. 2012 Oct;98(19):1431-5. doi: 10.1136/heartjnl-2012-302211. Epub 2012 Jul 31.

PMID:
22851684

Supplemental Content

Loading ...
Support Center